Stockreport

Ryvu Therapeutics provides an update on RVU120 Phase II program [Yahoo! Finance]

Exelixis, Inc.  (EXEL) 
Last exelixis, inc. earnings: 2/25 04:05 pm Check Earnings Report
PDF The company has successfully launched four Phase II clinical studies, with 106 clinical sites activated across six countries and 78 patients enrolled as of December 11, [Read more]